Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.20
HRC's Cash to Debt is ranked lower than
85% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.41 vs. HRC: 0.20 )
Ranked among companies with meaningful Cash to Debt only.
HRC' s 10-Year Cash to Debt Range
Min: 0.13  Med: 0.69 Max: 2.32
Current: 0.2
0.13
2.32
Equity to Asset 0.42
HRC's Equity to Asset is ranked lower than
76% of the 169 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. HRC: 0.42 )
Ranked among companies with meaningful Equity to Asset only.
HRC' s 10-Year Equity to Asset Range
Min: 0.17  Med: 0.44 Max: 0.67
Current: 0.42
0.17
0.67
Interest Coverage 12.51
HRC's Interest Coverage is ranked lower than
66% of the 104 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 38.48 vs. HRC: 12.51 )
Ranked among companies with meaningful Interest Coverage only.
HRC' s 10-Year Interest Coverage Range
Min: 5.45  Med: 10.89 Max: 25.97
Current: 12.51
5.45
25.97
F-Score: 6
Z-Score: 4.69
M-Score: -2.88
WACC vs ROIC
13.61%
8.32%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 7.21
HRC's Operating margin (%) is ranked higher than
56% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.07 vs. HRC: 7.21 )
Ranked among companies with meaningful Operating margin (%) only.
HRC' s 10-Year Operating margin (%) Range
Min: -27.59  Med: 11.20 Max: 19.59
Current: 7.21
-27.59
19.59
Net-margin (%) 4.89
HRC's Net-margin (%) is ranked higher than
56% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. HRC: 4.89 )
Ranked among companies with meaningful Net-margin (%) only.
HRC' s 10-Year Net-margin (%) Range
Min: -29.2  Med: 7.83 Max: 17.17
Current: 4.89
-29.2
17.17
ROE (%) 11.38
HRC's ROE (%) is ranked higher than
68% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.64 vs. HRC: 11.38 )
Ranked among companies with meaningful ROE (%) only.
HRC' s 10-Year ROE (%) Range
Min: -47.88  Med: 16.56 Max: 21.05
Current: 11.38
-47.88
21.05
ROA (%) 5.42
HRC's ROA (%) is ranked higher than
60% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.56 vs. HRC: 5.42 )
Ranked among companies with meaningful ROA (%) only.
HRC' s 10-Year ROA (%) Range
Min: -27.72  Med: 4.34 Max: 10.58
Current: 5.42
-27.72
10.58
ROC (Joel Greenblatt) (%) 22.84
HRC's ROC (Joel Greenblatt) (%) is ranked higher than
66% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. HRC: 22.84 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HRC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -66.76  Med: 32.59 Max: 96.41
Current: 22.84
-66.76
96.41
Revenue Growth (3Y)(%) 5.00
HRC's Revenue Growth (3Y)(%) is ranked higher than
51% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. HRC: 5.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HRC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -9.2  Med: 1.85 Max: 8.9
Current: 5
-9.2
8.9
EBITDA Growth (3Y)(%) -2.50
HRC's EBITDA Growth (3Y)(%) is ranked lower than
69% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. HRC: -2.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HRC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -63.4  Med: 0.05 Max: 134.9
Current: -2.5
-63.4
134.9
EPS Growth (3Y)(%) -20.80
HRC's EPS Growth (3Y)(%) is ranked lower than
85% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. HRC: -20.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HRC' s 10-Year EPS Growth (3Y)(%) Range
Min: -27.8  Med: 4.70 Max: 28.9
Current: -20.8
-27.8
28.9
» HRC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

HRC Guru Trades in Q2 2014

Paul Tudor Jones 14,000 sh (+33.33%)
David Dreman 228,119 sh (+10.13%)
Chuck Royce 521,470 sh (-0.53%)
Ken Fisher 1,706,884 sh (-2.76%)
Joel Greenblatt 90,281 sh (-44.00%)
John Keeley 481,948 sh (-68.18%)
» More
Q3 2014

HRC Guru Trades in Q3 2014

Jim Simons 7,400 sh (New)
Paul Tudor Jones 19,158 sh (+36.84%)
Chuck Royce 531,370 sh (+1.90%)
David Dreman 231,055 sh (+1.29%)
Ken Fisher 1,698,707 sh (-0.48%)
Joel Greenblatt 77,804 sh (-13.82%)
John Keeley 314,038 sh (-34.84%)
» More
Q4 2014

HRC Guru Trades in Q4 2014

Steven Cohen 825,600 sh (New)
Jim Simons 443,000 sh (+5886.49%)
Paul Tudor Jones 379,100 sh (+1878.81%)
David Dreman 241,924 sh (+4.70%)
Chuck Royce 534,570 sh (+0.60%)
John Keeley Sold Out
Ken Fisher 1,677,872 sh (-1.23%)
Joel Greenblatt 10,404 sh (-86.63%)
» More
Q1 2015

HRC Guru Trades in Q1 2015

Joel Greenblatt Sold Out
Ken Fisher 1,648,132 sh (-1.77%)
Chuck Royce 521,370 sh (-2.47%)
Jim Simons 400,300 sh (-9.64%)
Paul Tudor Jones 336,900 sh (-11.13%)
David Dreman 208,099 sh (-13.98%)
Steven Cohen 457,200 sh (-44.62%)
» More
» Details

Insider Trades

Latest Guru Trades with HRC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 35.40
HRC's P/E(ttm) is ranked lower than
60% of the 108 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.60 vs. HRC: 35.40 )
Ranked among companies with meaningful P/E(ttm) only.
HRC' s 10-Year P/E(ttm) Range
Min: 7.13  Med: 15.98 Max: 47.75
Current: 35.4
7.13
47.75
Forward P/E 19.72
HRC's Forward P/E is ranked higher than
64% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.32 vs. HRC: 19.72 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 35.40
HRC's PE(NRI) is ranked lower than
65% of the 110 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.50 vs. HRC: 35.40 )
Ranked among companies with meaningful PE(NRI) only.
HRC' s 10-Year PE(NRI) Range
Min: 8.58  Med: 18.78 Max: 53.13
Current: 35.4
8.58
53.13
P/B 4.25
HRC's P/B is ranked lower than
63% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.86 vs. HRC: 4.25 )
Ranked among companies with meaningful P/B only.
HRC' s 10-Year P/B Range
Min: 0.58  Med: 2.17 Max: 4.44
Current: 4.25
0.58
4.44
P/S 1.73
HRC's P/S is ranked higher than
68% of the 186 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.69 vs. HRC: 1.73 )
Ranked among companies with meaningful P/S only.
HRC' s 10-Year P/S Range
Min: 0.4  Med: 1.22 Max: 1.95
Current: 1.73
0.4
1.95
PFCF 29.30
HRC's PFCF is ranked lower than
51% of the 81 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.91 vs. HRC: 29.30 )
Ranked among companies with meaningful PFCF only.
HRC' s 10-Year PFCF Range
Min: 5.78  Med: 12.76 Max: 256.59
Current: 29.3
5.78
256.59
POCF 14.38
HRC's POCF is ranked higher than
68% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.68 vs. HRC: 14.38 )
Ranked among companies with meaningful POCF only.
HRC' s 10-Year POCF Range
Min: 3.32  Med: 8.49 Max: 69.21
Current: 14.38
3.32
69.21
EV-to-EBIT 26.03
HRC's EV-to-EBIT is ranked lower than
61% of the 117 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.23 vs. HRC: 26.03 )
Ranked among companies with meaningful EV-to-EBIT only.
HRC' s 10-Year EV-to-EBIT Range
Min: -19.8  Med: 12.20 Max: 28.4
Current: 26.03
-19.8
28.4
Shiller P/E 30.64
HRC's Shiller P/E is ranked higher than
52% of the 79 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.67 vs. HRC: 30.64 )
Ranked among companies with meaningful Shiller P/E only.
HRC' s 10-Year Shiller P/E Range
Min: 4.46  Med: 29.31 Max: 197.25
Current: 30.64
4.46
197.25
Current Ratio 1.85
HRC's Current Ratio is ranked lower than
64% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.55 vs. HRC: 1.85 )
Ranked among companies with meaningful Current Ratio only.
HRC' s 10-Year Current Ratio Range
Min: 1.33  Med: 2.30 Max: 3.1
Current: 1.85
1.33
3.1
Quick Ratio 1.43
HRC's Quick Ratio is ranked lower than
57% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.68 vs. HRC: 1.43 )
Ranked among companies with meaningful Quick Ratio only.
HRC' s 10-Year Quick Ratio Range
Min: 1.15  Med: 1.96 Max: 2.72
Current: 1.43
1.15
2.72
Days Inventory 55.21
HRC's Days Inventory is ranked higher than
87% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.70 vs. HRC: 55.21 )
Ranked among companies with meaningful Days Inventory only.
HRC' s 10-Year Days Inventory Range
Min: 31.31  Med: 44.95 Max: 68.91
Current: 55.21
31.31
68.91
Days Sales Outstanding 73.92
HRC's Days Sales Outstanding is ranked lower than
68% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 62.15 vs. HRC: 73.92 )
Ranked among companies with meaningful Days Sales Outstanding only.
HRC' s 10-Year Days Sales Outstanding Range
Min: 62.21  Med: 83.20 Max: 140.27
Current: 73.92
62.21
140.27

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.15
HRC's Dividend Yield is ranked lower than
60% of the 146 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.43 vs. HRC: 1.15 )
Ranked among companies with meaningful Dividend Yield only.
HRC' s 10-Year Dividend Yield Range
Min: 0.89  Med: 1.77 Max: 6.05
Current: 1.15
0.89
6.05
Dividend Payout 0.40
HRC's Dividend Payout is ranked higher than
59% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. HRC: 0.40 )
Ranked among companies with meaningful Dividend Payout only.
HRC' s 10-Year Dividend Payout Range
Min: 0.11  Med: 0.32 Max: 5.65
Current: 0.4
0.11
5.65
Dividend growth (3y) 11.40
HRC's Dividend growth (3y) is ranked higher than
61% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.10 vs. HRC: 11.40 )
Ranked among companies with meaningful Dividend growth (3y) only.
HRC' s 10-Year Dividend growth (3y) Range
Min: -28.8  Med: 6.15 Max: 11.4
Current: 11.4
-28.8
11.4
Yield on cost (5-Year) 1.70
HRC's Yield on cost (5-Year) is ranked higher than
51% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.66 vs. HRC: 1.70 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HRC' s 10-Year Yield on cost (5-Year) Range
Min: 1.31  Med: 2.61 Max: 8.93
Current: 1.7
1.31
8.93
Share Buyback Rate 2.90
HRC's Share Buyback Rate is ranked higher than
92% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. HRC: 2.90 )
Ranked among companies with meaningful Share Buyback Rate only.
HRC' s 10-Year Share Buyback Rate Range
Min: 3  Med: 0.50 Max: -0.9
Current: 2.9

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 31.34
HRC's Price/Tangible Book is ranked lower than
94% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. HRC: 31.34 )
Ranked among companies with meaningful Price/Tangible Book only.
HRC' s 10-Year Price/Tangible Book Range
Min: 1.46  Med: 3.09 Max: 28.32
Current: 31.34
1.46
28.32
Price/Projected FCF 1.79
HRC's Price/Projected FCF is ranked lower than
54% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. HRC: 1.79 )
Ranked among companies with meaningful Price/Projected FCF only.
HRC' s 10-Year Price/Projected FCF Range
Min: 0.37  Med: 0.91 Max: 9.08
Current: 1.79
0.37
9.08
Price/Median PS Value 1.43
HRC's Price/Median PS Value is ranked lower than
64% of the 163 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.24 vs. HRC: 1.43 )
Ranked among companies with meaningful Price/Median PS Value only.
HRC' s 10-Year Price/Median PS Value Range
Min: 0.35  Med: 0.85 Max: 1.57
Current: 1.43
0.35
1.57
Price/Graham Number 6.94
HRC's Price/Graham Number is ranked lower than
90% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. HRC: 6.94 )
Ranked among companies with meaningful Price/Graham Number only.
HRC' s 10-Year Price/Graham Number Range
Min: 0.64  Med: 1.16 Max: 7.08
Current: 6.94
0.64
7.08
Earnings Yield (Greenblatt) (%) 3.80
HRC's Earnings Yield (Greenblatt) (%) is ranked higher than
60% of the 179 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.80 vs. HRC: 3.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HRC' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 3.5  Med: 7.60 Max: 17.7
Current: 3.8
3.5
17.7
Forward Rate of Return (Yacktman) (%) 2.00
HRC's Forward Rate of Return (Yacktman) (%) is ranked lower than
70% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.10 vs. HRC: 2.00 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HRC' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -24.4  Med: 3.30 Max: 20.5
Current: 2
-24.4
20.5

Analyst Estimate

Sep15 Sep16
EPS($) 2.54 2.75
EPS without NRI($) 2.54 2.75

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:HB9.Germany,
Hill-Rom Holdings Inc was incorporated on August 7, 1969 in the State of Indiana. The Company is a manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions. The Company's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings worldwide, to enhance the safety and quality of patient care. The Company operates in three segments namely North America, Surgical and Respiratory Care and International. The North America segment sells and rents its patient support and near-patient technologies and services, as well as health information technology solutions in the U.S. and Canada. The Surgical and Respiratory Care segment sells and rents surgical and respiratory care products. The International segment sells and rents its products outside of the U.S. and Canada. The Company sells and rent its product to acute and extended care health care facilities through both direct sales force and distributors. It also sell products to patients in the home. Through its network of approximately 160 North American and 50 international service centers, and approximately 1,100 North American and 375 international service professionals. It competes on the basis of clinical expertise and resulting product clinical utility and ability to produce favorable outcomes, as well as value, quality, customer service, innovation and breadth and depth of product offerings. It competitors include: Stryker Corporation, SIZEWise Rentals, LLC, Universal Hospital Services, Inc., Rauland-Borg Corporation and among others. The Company owns a number of trademarks and service marks relating to its products and product services. The Company is subject to laws and regulations at both the federal and state levels.
» More Articles for HRC

Headlines

Articles On GuruFocus.com
Hill-Rom Q2 Earnings Beat Market Estimates May 09 2015 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 21,029 Shares Dec 07 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 18,893 Shares Dec 03 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 20,005 Shares Nov 23 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 9,757 Shares Nov 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 33,670 Shares Nov 12 2010 
HILL-ROM HOLDINGS, INC. (HRC) SENIOR VP, CFO & TREASURER Gregory N Miller sells 25,967 Shares Nov 08 2010 
Weekly CEO Buys Highlight: AOL Inc, Consolidated Graphics Inc, Saul Centers Inc, Hill-ROM Holdings, May 16 2010 
HILL-ROM HOLDINGS, INC. (HRC) CEO John J Greisch buys 30,000 Shares May 12 2010 
HILL-ROM HOLDINGS, INC. Reports Operating Results (10-Q) Feb 04 2010 

More From Other Websites
Advanced Monitoring System Dramatically Improves Hand Washing by Health Care Workers Jun 26 2015
G-III Apparel Looks to Broaden M&A Collection Jun 22 2015
Edited Transcript of HRC M&A conference call or presentation 17-Jun-15 12:00pm GMT Jun 18 2015
Top Stock CyberArk Leads New Highs As Market Recovers Jun 17 2015
FedEx and Hill-Rom are big market movers Jun 17 2015
FedEx and Hill-Rom are big market movers Jun 17 2015
Mid-Afternoon Market Update: DavidsTea Falls After Q1 Results; Synergy Pharmaceuticals Shares Spike... Jun 17 2015
Mid-Day Market Update: Kythera Biopharmaceuticals Jumps On Acquisition News; La-Z-Boy Shares Slide Jun 17 2015
Hill-Rom (HRC) Stock Surging After $2 Billion Deal for Welch Allyn Jun 17 2015
HILL-ROM HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Jun 17 2015
Early movers: FDX, KYTH, HRC, PFE, LLY & more Jun 17 2015
Hill-Rom To Acquire Welch Allyn Creating Global Leader In Patient Care Solutions Jun 17 2015
Hill-Rom to acquire Welch Allyn for about $2.05 bln Jun 17 2015
Hill-Rom To Acquire Welch Allyn Creating Global Leader In Patient Care Solutions Jun 17 2015
Hill-Rom (HRC) Poised on Organic Growth, Trumpf Integration - Analyst Blog Jun 09 2015
Vista Outdoor Inc (VSTO), Hill-Rom Holdings, Inc. (HRC), West Corp (WSTC): Alyeska Investment’s... Jun 08 2015
Hill-Rom to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference May 26 2015
Hill-Rom to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference May 26 2015
New Solutions from Hill-Rom Working to Transform Bariatric Care May 20 2015
New Solutions from Hill-Rom Working to Transform Bariatric Care May 20 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK